
Sign up to save your podcasts
Or
This is the sixth episode of our ongoing "Program on JAK Inhibitors for Atopic Dermatitis" series, hosted by expert dermatologist Dr. Christopher Bunick, MD, PhD. This episode, "Achieving More: How and When to Switch Systemic Therapies in Atopic Dermatitis?", featuring Beth Sweney, PA-C discusses the following topics:
Challenges in achieving treatment targets in AD
Therapeutic inertia and clinical implications of inadequate response
Comparative clinical data evaluating upadacitinib and dupilumab for treatment of AD
Transitioning to systemic therapies from topical agents, immunosuppressives, and biologic therapies
5
55 ratings
This is the sixth episode of our ongoing "Program on JAK Inhibitors for Atopic Dermatitis" series, hosted by expert dermatologist Dr. Christopher Bunick, MD, PhD. This episode, "Achieving More: How and When to Switch Systemic Therapies in Atopic Dermatitis?", featuring Beth Sweney, PA-C discusses the following topics:
Challenges in achieving treatment targets in AD
Therapeutic inertia and clinical implications of inadequate response
Comparative clinical data evaluating upadacitinib and dupilumab for treatment of AD
Transitioning to systemic therapies from topical agents, immunosuppressives, and biologic therapies
132 Listeners